1. bookVolume 42 (2021): Issue 2 (October 2021)
Journal Details
License
Format
Journal
eISSN
1857-8985
First Published
08 Sep 2014
Publication timeframe
2 times per year
Languages
English
access type Open Access

High Risk Percutaneous Coronary Intervention of Left Main Bifurcation Stenosis in a Peritoneal Dialysis Patient

Published Online: 26 Oct 2021
Volume & Issue: Volume 42 (2021) - Issue 2 (October 2021)
Page range: 71 - 78
Journal Details
License
Format
Journal
eISSN
1857-8985
First Published
08 Sep 2014
Publication timeframe
2 times per year
Languages
English
Abstract

Complex coronary artery disease is the leading cause of death in patients with end-stage renal disease. We report a case of a patient on peritoneal dialysis, preloaded with Prasugrel and acetylsalicylic acid as а potent dual antiplatelet therapy (DAPT). The patient underwent a high-risk percutaneous coronary intervention (PCI) due to bifurcation stenosis of the left main stem branch. A “double kiss crush” bifurcation stenting technique was performed. This case provides additional data about the treatment of this group of patients, a group that is often excluded from randomized control trials, but is frequently encountered in cardiovascular practice. Furthermore, it helps to advance PCI treatment along with exploring the safety of potent DAPT in a group that is susceptible to both ischemia and bleeding, thus presenting a great challenge in the decision for treatment.

Keywords

1. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl. 2003;64:S24–S31.10.1046/j.1523-1755.64.s87.5.x Search in Google Scholar

2. Reddan DN, Szczech LA, Tuttle RH Jr., Shaw KL, Jones HR, Schwab JS, et al.. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol. 2003;14(9):2373–2380.10.1097/01.ASN.0000083900.92829.F5 Search in Google Scholar

3. Patel B, Shah M, Dusaj R, Maynard S, Patel N. Percutaneous coronary intervention and inpatient mortality in patients with advanced chronic kidney disease presenting with acute coronary syndrome. Proc (Bayl Univ Med Cent). 2017;30(4):400-403.10.1080/08998280.2017.11930205 Search in Google Scholar

4. Piccolo R, Giustino G, Mehran R, Windecker S. Stable coronary artery disease: revascularization and invasive strategies. Lancet 2015; 386:70210.1016/S0140-6736(15)61220-X Search in Google Scholar

5. Milojevic M, Head SJ, Mack MJ, Mohr FW, Morice MC, Dawkins KD, et al. The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial. Eurointervention 2018;14:102–111.10.4244/EIJ-D-17-0062029155387 Search in Google Scholar

6. Giustino G, Mehran R, Serruys PW, Sabik JF 3rd, Milojevic M, Simonton CA, et al. Left main revascularization with PCI or CABG in patients with chronic kidney disease: EXCEL trial. J Am Coll Cardiol. 2018;72:754-765.10.1016/j.jacc.2018.05.05730092952 Search in Google Scholar

7. Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. (2015) Revascularization in patients with multivessel coronary artery disease and chronic kidney disease: everolimus-eluting stents versus coronary artery bypass graft surgery. J Am Coll Cardiol 66:1209–1220.10.1016/j.jacc.2015.06.1334494484526361150 Search in Google Scholar

8. Louvard Y, Medina A. Definitions and classifications of bifurcation lesions and treatment. Euro-Intervention. 2015;11 Suppl V:V23-6.10.4244/EIJV11SVA525983165 Search in Google Scholar

9. SYNTAX score. http://www.syntaxscore.com/index.php.Последнапосетана 13.02.2021 г. Search in Google Scholar

10. Torres IR, Mercader SI, Rumbeu CC, Gil J, Cervelló F, Viana MM, et al. Long-term prognosis of chronic kidney disease in non-ST elevation acute coronary syndrome treated with invasive strategy. Nefrología (English Edition) 2017.37(3):276-284.10.1016/j.nefroe.2017.06.001 Search in Google Scholar

11. Menéndez EG, Vidas MM, Alique M, Carracedo J, Sequera P, Corchete E, et al. Statins and anti-platelet agents are associated with changes in the circulatory markers of endothelial dysfunction in chronic kidney disease. Nefrología (English Edition) 2019;39(3): 287-293.10.1016/j.nefroe.2019.01.002 Search in Google Scholar

12. Kashiyama K, Sonoda S, Muraoka Y., Suzuki Y, Kamezaki F, Tsuda, Y, et al. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study. Int J Cardiovasc Imaging 2015;31:935–945.10.1007/s10554-015-0633-y Search in Google Scholar

13. Wang C, Cheng G, Duanmu Y, Zhu Y, Xu L. Correlation of coronary plaque characteristics and obstructive stenosis with chronic kidney disease by coronary CT angiography. Cardiovasc Diagn Ther. 2015;5(6):435-443. Search in Google Scholar

14. Chen W, Melamed ML. Vascular calcification in predialysis CKD: Common and deadly. Clinical J Am Soc Nephrology 2015;10(4):551-553.10.2215/CJN.01940215 Search in Google Scholar

15. Conti CR, Selby JH, Christie LG, Pepine CJ, Curry Jr RC, Nichols WW, et al. Left main coronary artery stenosis: clinical spectrum, patho-physiology, and management. Prog Cardiovasc Dis. 1979;22(2):73–106.10.1016/0033-0620(79)90016-1 Search in Google Scholar

16. Sousa-Uva M, Neumann FJ, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2019 Jan 1;55(1):4-90. Search in Google Scholar

17. Amsterdam EA, Wenger NK, Brindis RG, Casey Jr ED, Ganiats GT, Holmes Jr RD, et al. AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;64:e139–e228.10.1016/j.jacc.2014.09.017 Search in Google Scholar

18. Holm RN, Makikallio T, Lindsay MM, Spence SM, Erglis A, Menown BI, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomized, non-inferiority NOBLE trial. Lancet 2019;395(10219):191-199.10.1016/S0140-6736(19)32972-1 Search in Google Scholar

19. Han-Yan L, Chih-Hsiang C, Cheng-Chia L, Chien-Chia W, Dong-Yi C, Pao-Hsien C, et al. Risk analysis of dialysis-dependent patients who underwent coronary artery bypass grafting. Medicine 2017; 96(39):e814610.1097/MD.0000000000008146 Search in Google Scholar

20. Wang Z, Gong Y, Fan F, Yang F, Qiu L, Hong T, Huo Y. Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis. Ren Fail. 2020;42(1):107-112.10.1080/0886022X.2019.1710187 Search in Google Scholar

21. Riley RF, Henry TD, Mahmud E, Kirtane JA, Brilakis E, Goyal A, et al. SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease. Catheter Cardiovasc Interv. 2020;96:346–362.10.1002/ccd.28994 Search in Google Scholar

22. SUMMARY OF PRODUCT CHARACTERISTICS: PRASUGREL https://www.ema.europa.eu/en/documents/product-information/prasugrel-mylan-epar-product-information_en.pdf. Последна посета на 13.02.2021 г. Search in Google Scholar

23. Summaria F, Giannico MB, Talarico GP, Patrizi R. Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions. Nephrourol Mon. 2015;7(4):e2809910.5812/numonthly.28099 Search in Google Scholar

24. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRI-TON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009;373(9665):723–31.10.1016/S0140-6736(09)60441-4 Search in Google Scholar

25. Small DS, Wrishko RE, Ernest Ii CS, Ni L, Winters KJ, Farid NA, et al. Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease. J Clin Pharm Ther. 2009;34(5):585–94.10.1111/j.1365-2710.2009.01068.x19744014 Search in Google Scholar

26. Park S, KimY, Jo AH, Lee S, Kim M-S, Yang RB, et al. Clinical outcomes of prolonged dual antiplatelet therapy after coronary drug-eluting stent implantation in dialysis patients. Clin Kidney J, 2020;13(5):803–812.10.1093/ckj/sfaa037757776233125004 Search in Google Scholar

27. Amabile N, Rangé G, Souteyrand G, Godin M, Boussaada MM, Meneveau N, et al. Optical Coherence Tomography to Guide Percutaneous Coronary Intervention of the Left Main Coronary Artery: the LEMON study. EuroIntervention 2020; Jaa-868.10.4244/EIJ-D-20-0112133226003 Search in Google Scholar

28. Takagi K., Nagoshi R, Kim BK,, Kim W, Kinoshita Y, Shite J, et al. Efficacy of coronary imaging on bifurcation intervention. Cardiovasc Interv and Ther 2021;36:54–6610.1007/s12928-020-00701-2782922632894433 Search in Google Scholar

29. Cortese B, Burzotta F, Alfonso F, Pellegrini D, Trani C, Aurigemma C, et al. Role of optical coherence tomography for distal left main stem angioplasty. Catheter Cardiovasc Interv.2019;1–7.10.1002/ccd.2854731631525 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo